Maternal serum glycosylated fibronectin as a short-term predictor of preeclampsia: a prospective cohort study.
Evelyn Annegret HuhnIna HoffmannBegoña Martinez De TejadaSoeren LangeKylie M SageCharles T RobertsMichael G GravettSrinivasa R NagallaOlav LapairePublished in: BMC pregnancy and childbirth (2020)
In this prospective cohort, serum biomarkers of biochemical disease were effective in short-term prediction of preeclampsia, and the performance of GlyFn in particular as a POC test may meet the needs of rapid and accurate triage and intervention.